Astal Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)
Astal Laboratories Ltd · Outcome · 14 Nov 2026, 1:27 am
Astal Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 10,794 (+187.7% YoY | +6.9% QoQ) ■ EBITDA: 1,729 (+347.0% YoY | +41.2% QoQ) ■ EBITDA Margin (%): 16.0 (+571 bps YoY | +389 bps QoQ) ■ PAT: 977 (+278.3% YoY | +3.7% QoQ) ■ EPS (INR): 2.22 (+12.6% YoY | +2.0% QoQ)
Original exchange filing (PDF)
More announcements from Astal Laboratories Ltd
- Submission of statement of Deviation and variation for September 2026 quarter. · 14 Nov 2026
- Submission of Financial Results. · 14 Nov 2026
- Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the unaudited standalone .... · 13 Nov 2026
- Submission of Voting Results. · 01 Oct 2026
- Submission of voting Results with scrutinizers report. · 01 Oct 2026
- Attached. · 30 Sept 2026
- Attached · 30 Sept 2026
- Submission of outcome of 33rd Annual General Meeting. · 29 Sept 2026
